Remove 2007 Remove Government Remove Provider Remove Utilities
article thumbnail

Skinny Label and Induced Infringement: The Saga Continues

FDA Law Blog

government in the now-infamous (at least in FDA circles) Teva v. In the brief , the Government takes a strong position, stating “[t]he court of appeals’ holding that respondents presented sufficient evidence of petitioner’s intent to induce infringement is erroneous and warrants this Court’s review.” GSK skinny label case , the U.S.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law Blog

Though the carve-out seems at odds with FDA’s regulations requiring generic drugs to have the “same labeling” as their RLDs, such regulations specifically provide for differences arising from carved-out, patent-protected method of use. Teva received tentative approval in June 2003 and launched in 2007 after a blocking patent expired.

IT 52
article thumbnail

Health and Wealth Shocks: Lauren Hunt, Rebecca Rodin, Tsai-Chin Cho

GeriPal

And the government can do something about that?!? And so spouses are typically the ones for patients who provide most of the caregiving support. And that’s in addition to the financial, emotional companionship, and psychosocial support that spouses typically provide. Cai Chin, can you tell us more?

Illness 73